Log in to save to my catalogue

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-smal...

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-smal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4788951

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

About this item

Full title

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2016-03, Vol.16 (1), p.210-210, Article 210

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Despite reported discordance between the mutational status of primary lung cancers and their metastases, metastatic sites are rarely biopsied and targeted therapy is guided by genetic biomarkers detected in the primary tumor. This situation is mostly explained by the apparent stability of EGFR-activating mutations. Given the dramatic increase in th...

Alternative Titles

Full title

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4788951

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4788951

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-016-2249-6

How to access this item